In a DSS‐colitis recovery model, WMP promoted recovery as evidenced by improved weight gain, reduced stool scores, reduced IL‐1β levels, and myeloperoxidase (MPO) activity in colonic tissue. This evidence concerns the gene IL1B and colitis.